{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:03:15Z","timestamp":1792627395668,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010201","name":"US Army Medical Research Institute of Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010201","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.virusres.2023.199173","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T14:39:26Z","timestamp":1690209566000},"page":"199173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Induced protection from a CCHFV-M DNA vaccine requires CD8+ T cells"],"prefix":"10.1016","volume":"334","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9709-313X","authenticated-orcid":false,"given":"Joseph W.","family":"Golden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin J.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Suschak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara L.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2854-9308","authenticated-orcid":false,"given":"Keersten M.","family":"Ricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Sanchez-Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3034-6400","authenticated-orcid":false,"given":"Aura R.","family":"Garrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2023.199173_bib0001","unstructured":"World Health Organization, 2015. Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens. December 8-9."},{"key":"10.1016\/j.virusres.2023.199173_bib0002","unstructured":"World Health Organization, 2018. 2018 Annual review of diseases prioritized under the Research and Development Blueprint."},{"issue":"3","key":"10.1016\/j.virusres.2023.199173_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7030115","article-title":"Immunological analysis of a CCHFV mRNA vaccine candidate in mouse models","volume":"7","author":"Aligholipour Farzani","year":"2019","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.virusres.2023.199173_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/v11030237","article-title":"Bovine herpesvirus type 4 (BoHV-4) vector delivering nucleocapsid protein of crimean-congo hemorrhagic fever virus induces comparable protective immunity against lethal challenge in IFNalpha\/beta\/gammaR-\/- Mice Models","volume":"11","author":"Aligholipour Farzani","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.virusres.2023.199173_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01568-21","article-title":"Nucleoside-modified mRNA vaccines protect IFNAR(-\/-) mice against crimean-congo hemorrhagic fever virus infection","volume":"96","author":"Appelberg","year":"2022","journal-title":"J. Virol."},{"issue":"Pt 4","key":"10.1016\/j.virusres.2023.199173_bib0006","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1099\/jmm.0.45865-0","article-title":"Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures","volume":"54","author":"Bakir","year":"2005","journal-title":"J Med Microbiol"},{"issue":"21","key":"10.1016\/j.virusres.2023.199173_bib0007","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1128\/JVI.01383-10","article-title":"Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model","volume":"84","author":"Bente","year":"2010","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2023.199173_bib0008","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"Bente","year":"2013","journal-title":"Antiviral Res."},{"issue":"Pt 6","key":"10.1016\/j.virusres.2023.199173_bib0009","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1099\/vir.0.019034-0","article-title":"Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice","volume":"91","author":"Bereczky","year":"2010","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2023.199173_bib0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/intimm\/14.4.411","article-title":"IFN-alpha\/beta enhances BCR-dependent B cell responses","volume":"14","author":"Braun","year":"2002","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.virusres.2023.199173_bib0011","doi-asserted-by":"crossref","first-page":"e91516","DOI":"10.1371\/journal.pone.0091516","article-title":"A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model","volume":"9","author":"Buttigieg","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.virusres.2023.199173_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003579","article-title":"Immunization of knock-out alpha\/beta interferon receptor mice against high lethal dose of Crimean-Congo hemorrhagic fever virus with a cell culture based vaccine","volume":"9","author":"Canakoglu","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.virusres.2023.199173_bib0013","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3201\/eid2101.141413","article-title":"Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009","volume":"21","author":"Conger","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virusres.2023.199173_bib0014","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14115.1","article-title":"CD8 (+) T-cell responses in vaccination: reconsidering targets and function in the context of chronic antigen stimulation","volume":"7","author":"Cosma","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.virusres.2023.199173_bib0015","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Council","year":"2011"},{"issue":"6","key":"10.1016\/j.virusres.2023.199173_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156637","article-title":"Protective effects of a modified vaccinia ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses","volume":"11","author":"Dowall","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.virusres.2023.199173_bib0017","doi-asserted-by":"crossref","first-page":"7298","DOI":"10.1038\/s41467-022-34923-0","article-title":"Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus","volume":"13","author":"Durie","year":"2022","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.virusres.2023.199173_bib0018","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1016\/j.cell.2021.05.001","article-title":"Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever","volume":"184","author":"Fels","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.virusres.2023.199173_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10080956","article-title":"Immunodominant cytomegalovirus epitopes suppress subdominant epitopes in the generation of high-avidity CD8 T Cells","volume":"10","author":"Freitag","year":"2021","journal-title":"Pathogens"},{"issue":"11","key":"10.1016\/j.virusres.2023.199173_bib0020","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/15200","article-title":"Natural adjuvants: endogenous activators of dendritic cells","volume":"5","author":"Gallucci","year":"1999","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.virusres.2023.199173_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005908","article-title":"A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models","volume":"11","author":"Garrison","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"12","key":"10.1016\/j.virusres.2023.199173_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006064","article-title":"Effective respiratory CD8 T-cell immunity to influenza virus induced by intranasal carbomer-lecithin-adjuvanted non-replicating vaccines","volume":"12","author":"Gasper","year":"2016","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.virusres.2023.199173_bib0023","doi-asserted-by":"crossref","first-page":"eaaw9535","DOI":"10.1126\/sciadv.aaw9535","article-title":"GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection","volume":"5","author":"Golden","year":"2019","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.virusres.2023.199173_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010485","article-title":"The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected mice","volume":"18","author":"Golden","year":"2022","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.virusres.2023.199173_bib0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41564-020-00815-6","article-title":"A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model","volume":"6","author":"Hawman","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virusres.2023.199173_bib0026","article-title":"Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model","author":"Hawman","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2023.199173_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02076-16","article-title":"Immunization with DNA plasmids coding for crimean-congo hemorrhagic fever virus capsid and envelope proteins and\/or virus-like particles induces protection and survival in challenged mice","author":"Hinkula","year":"2017","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virusres.2023.199173_bib0028","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/vbz.2015.1855","article-title":"Crimean-Congo hemorrhagic fever virus subunit vaccines induce high levels of neutralizing antibodies but no protection in STAT1 knockout mice","volume":"15","author":"Kortekaas","year":"2015","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.virusres.2023.199173_bib0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijid.2015.06.029","article-title":"Consensus report: preventive measures for Crimean-Congo Hemorrhagic Fever during Eid-al-Adha festival","volume":"38","author":"Leblebicioglu","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virusres.2023.199173_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104188","article-title":"Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge","volume":"82","author":"Leventhal","year":"2022","journal-title":"EBioMedicine"},{"issue":"21","key":"10.1016\/j.virusres.2023.199173_bib0031","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01083-18","article-title":"Exploring crimean-congo hemorrhagic fever virus-induced hepatic injury using antibody-mediated type i interferon blockade in mice","volume":"92","author":"Lindquist","year":"2018","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2023.199173_bib0032","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4049\/jimmunol.161.4.1947","article-title":"Type I IFNs enhance the terminal differentiation of dendritic cells","volume":"161","author":"Luft","year":"1998","journal-title":"J. Immunol."},{"issue":"6576","key":"10.1016\/j.virusres.2023.199173_bib0033","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.abl6502","article-title":"Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies","volume":"375","author":"Mishra","year":"2022","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.virusres.2023.199173_bib0034","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/00365548.2010.540036","article-title":"The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain","volume":"43","author":"Papa","year":"2010","journal-title":"Scand J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virusres.2023.199173_bib0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ilar\/ily026","article-title":"Immune relevant and immune deficient mice: options and opportunities in translational research","volume":"59","author":"Radaelli","year":"2018","journal-title":"ILAR J."},{"issue":"3","key":"10.1016\/j.virusres.2023.199173_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens8030147","article-title":"Contribution of resident memory CD8(+) T cells to protective immunity against respiratory syncytial virus and their impact on vaccine design","volume":"8","author":"Retamal-Diaz","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.virusres.2023.199173_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104523","article-title":"Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model","volume":"90","author":"Saunders","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virusres.2023.199173_bib0038","series-title":"Fields Virology","first-page":"1741","article-title":"Bunyaviridae","author":"Schmaljohn","year":"2007"},{"issue":"1","key":"10.1016\/j.virusres.2023.199173_bib0039","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/22221751.2019.1601030","article-title":"Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice","volume":"8","author":"Scholte","year":"2019","journal-title":"Emerg. Microbes Infect."},{"issue":"11","key":"10.1016\/j.virusres.2023.199173_bib0040","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1089\/jir.2006.26.804","article-title":"Blocking monoclonal antibodies specific for mouse IFN-alpha\/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection","volume":"26","author":"Sheehan","year":"2006","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.virusres.2023.199173_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005296","article-title":"Neuropathogenesis of Zika Virus in a Highly Susceptible immunocompetent mouse model after antibody blockade of type I interferon","volume":"11","author":"Smith","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.virusres.2023.199173_bib0042","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41541-021-00293-9","article-title":"A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice","volume":"6","author":"Suschak","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"2","key":"10.1016\/j.virusres.2023.199173_bib0043","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4049\/jimmunol.1402530","article-title":"Identification of Aim2 as a sensor for DNA vaccines","volume":"194","author":"Suschak","year":"2015","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.virusres.2023.199173_bib0044","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/QCO.0b013e3282a56a0a","article-title":"Crimean-Congo hemorrhagic fever","volume":"20","author":"Vorou","year":"2007","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.virusres.2023.199173_bib0045","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/infdis\/jit061","article-title":"Lethal Crimean-Congo hemorrhagic fever virus infection in interferon alpha\/beta receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy","volume":"207","author":"Zivcec","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.virusres.2023.199173_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006628","article-title":"Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge","volume":"12","author":"Zivcec","year":"2018","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170223001351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170223001351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:22:54Z","timestamp":1759155774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170223001351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":46,"alternative-id":["S0168170223001351"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2023.199173","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induced protection from a CCHFV-M DNA vaccine requires CD8+ T cells","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2023.199173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199173"}}